Premarital screening for thalassemia and sickle cell disease in Saudi Arabia

Genetics in Medicine

Volumn 9, Issue 6, 2007, Pages 372-377

  AlHamdan, Nasser AbdulRahman ^a   AlMazrou, Yagob Yousaf ^a   AlSwaidi, Fahad Mohammad ^a   Choudhry, Abdul Jamil ^a,b  

^a MINISTRY OF HEALTH   (Saudi Arabia)

^b Field Epidemiology Training Program   (Saudi Arabia)

Author keywords

Premarital; Saudi Arabia; Screening; Sickle cell disease; Thalassemia

Indexed keywords

ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC SCREENING; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; MALE; MARRIAGE; POPULATION RESEARCH; PREVALENCE; SAUDI ARABIA; SICKLE CELL ANEMIA; THALASSEMIA;

ANEMIA, SICKLE CELL; FEMALE; GENETIC SCREENING; HUMANS; MALE; PREMARITAL EXAMINATIONS; SAUDI ARABIA; THALASSEMIA;

EID: 34250706276     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e318065a9e8     Document Type: Article

References (16)

1. Wild BJ, Bain BJ. Investigation of abnormal hemoglobins and thalassemia. In: Lewis SM, Bain BJ, Bates I, editors. Dacie & Lewis practical hematology, 9th edition. London: Churchill Livingstone, 2001:231-268.
2. El-Hazmi AF, Warsy AS. Hemoglobinopathies in Arab countries. In: Teebi AS, Farag TI, editors. Genetic disorders among Arab populations. Oxford monographs on medical genetics, No. 30. New York: Oxford University Press, 1999:83-110.
3. El-Hazmi MAF, Warsy AS. Appraisal of sickle cell and thalassemia genes in Saudi Arabia. East Mediterr Health J 1999;5:1147-1153.
4. Rashad H, Osman M, Roudi-Fahimi F. Marriage in the Arab world. Washington: Population Reference Bureau, 2005.
5. Meyer BF. Strategies for the prevention of hereditary diseases in a highly consanguineous population. Ann Hum Biol 2005;32:174-179.
6. Caughey AB. Cost-effectiveness analysis of prenatal diagnosis: methodological issues and concerns. Gynecol Obstet Invest 2005;60:11-18.
7. Almeida AM, Henthorn JS, Davies SC. Neonatal screening for haemoglobinopathies: the results of a 10-year programme in an English Health Region. Br J Haematol 2001;112:32-35.
8. Ministry of Economic and Planning, Kingdom of Saudi Arabia. Preliminary results of the census operation 1425 H-2005. Available at http://www.planning. gov.sa/ statistic/cdsonnet/demographicmap/escripts/prepop.asp. Accessed September 6, 2006.
9. Ministry of Health, Kingdom of Saudi Arabia. Statistical Year Book 1424 Hijri. Riyadh: Ministry of Health, 2006:105.
10. Kirkwood BR, Sterne JAC. Essential medical statistics, 2nd edition. Massachusetts: Blackwell Science, 2003:143-144.
11. Al Hosani H, Salah M, Osman HM, Farag HM, Anvery SM. Incidence of haemoglobinopathies detected through neonatal screening in the United Arab Emirates. East Mediterr Health J 2005;11:300-307.
12. Al-Riyami A, Ebrahim GJ. Genetic blood disorders survey in the sultanate of Oman. J Trop Pediatr 2003;49 Suppl 1:i1-20.
13. Kadkhodaei Elyaderani M, Cinkotai KI, Hyde K, Waters HM, Howarth J, Goldstone S, et al. Ethnicity study and non-selective screening for haemoglobinopathies in the antenatal population of central Manchester. Clin Lab Haematol 1998;20:207-211.
14. Madi SA, Al-Naggar RL, Al-Awadi SA, Bastaki LA. Profile of major congenital malformations in neonates in Al-Jahra region of Kuwait. East Mediterr Health J 2005;11:700-706.
15. Hussain R. Community perceptions of reasons for preference for consanguineous marriages in Pakistan. J Biosoc Sci 1999;31:449-461.
16. Autti-Ramo I, Makela M, Sintonen H, Koskinen H, Laajalahti L, et al. Expanding screening for rare metabolic disease in the newborn: an analysis of costs, effect and ethical consequences for decision-making in Finland. Acta Paediatr 2005;94:1126-1136.